Headquartered in London, Stallergenes Greer Ltd. is a global biopharmaceutical company specialising in allergy immunotherapy products and services.

Formed by the merger in 2015 of the two companies that make up its name - the former based in France, the latter in the US - Stallergenes Greer has centres in 19 countries and manufacturing facilities in both Europe and the USA.